Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Evolving immunosuppressive microenvironment during human cervical carcinogenesis.

Kobayashi A, Weinberg V, Darragh T, Smith-McCune K.

Mucosal Immunol. 2008 Sep;1(5):412-20. doi: 10.1038/mi.2008.33.

PMID:
19079205
2.
4.

Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.

Kobayashi A, Greenblatt RM, Anastos K, Minkoff H, Massad LS, Young M, Levine AM, Darragh TM, Weinberg V, Smith-McCune KK.

Cancer Res. 2004 Sep 15;64(18):6766-74.

5.
6.

Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.

Hu T, Yang P, Zhu H, Chen X, Xie X, Yang M, Liu S, Wang H.

Diagn Pathol. 2015 Apr 2;10:20. doi: 10.1186/s13000-015-0254-8.

7.

Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B, Venzon DJ, Shearer GM, De Palo G, Clerici E.

J Natl Cancer Inst. 1997 Feb 5;89(3):245-50.

8.

Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7.

Mittal D, Kassianos AJ, Tran LS, Bergot AS, Gosmann C, Hofmann J, Blumenthal A, Leggatt GR, Frazer IH.

J Invest Dermatol. 2013 Dec;133(12):2686-94. doi: 10.1038/jid.2013.222.

9.

[Expressions of Th, DC, NK cells in cervical tissue and the relationship with immune functions].

Ma C, Zhang WY, Wang JD.

Zhonghua Yi Xue Za Zhi. 2009 Jun 16;89(23):1650-3. Chinese.

PMID:
19957517
10.

IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.

DeCarlo CA, Severini A, Edler L, Escott NG, Lambert PF, Ulanova M, Zehbe I.

Lab Invest. 2010 Oct;90(10):1482-91. doi: 10.1038/labinvest.2010.95.

11.
12.

B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.

Wang X, Wang T, Xu M, Xiao L, Luo Y, Huang W, Zhang Y, Geng W.

Hum Immunol. 2014 Dec;75(12):1203-9. doi: 10.1016/j.humimm.2014.10.002.

PMID:
25446402
13.

Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix.

Sharma A, Rajappa M, Saxena A, Sharma M.

Int J Gynecol Cancer. 2007 Jul-Aug;17(4):879-85.

PMID:
17343606
14.

Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.

Feng Q, Wei H, Morihara J, Stern J, Yu M, Kiviat N, Hellstrom I, Hellstrom KE.

Gynecol Oncol. 2012 Nov;127(2):412-9. doi: 10.1016/j.ygyno.2012.07.098.

15.

Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.

Scott ME, Ma Y, Kuzmich L, Moscicki AB.

Int J Cancer. 2009 Mar 15;124(6):1379-83. doi: 10.1002/ijc.24117.

16.

Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia.

Tjiong MY, van der Vange N, ter Schegget JS, Burger MP, ten Kate FW, Out TA.

Cytokine. 2001 Jun 21;14(6):357-60.

PMID:
11497498
17.

A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.

Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer CJ, Snijders PJ, Helmerhorst TJ.

J Clin Pathol. 2005 Oct;58(10):1096-100.

18.

Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.

Kojima S, Kawana K, Fujii T, Yokoyama T, Miura S, Tomio K, Tomio A, Yamashita A, Adachi K, Sato H, Nagamatsu T, Schust DJ, Kozuma S, Taketani Y.

Am J Reprod Immunol. 2011 Nov;66(5):435-43. doi: 10.1111/j.1600-0897.2011.01041.x.

PMID:
21749545
19.

Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.

Roy S, Barik S, Banerjee S, Bhuniya A, Pal S, Basu P, Biswas J, Goswami S, Chakraborty T, Bose A, Baral R.

Hum Immunol. 2013 Aug;74(8):1015-23. doi: 10.1016/j.humimm.2013.04.022.

PMID:
23628394
20.

MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study.

Brummer O, Böhmer G, Hollwitz B, Flemming P, Petry KU, Kühnle H.

Gynecol Oncol. 2002 Feb;84(2):222-7.

PMID:
11812078
Items per page

Supplemental Content

Support Center